CTMX · CytomX Therapeutics, Inc. · Share Buybacks
$2.04
+0.00 (+0.00%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$444.73M
Shares
218.00M
Volume · Nov 13
2.72M
Avg daily vol (3M)
4.16M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2020-02-27 | 2024-08-09 | $75,000,000 | — | — | 10-Q , filed 2025-11-06 |
Key facts
CIK
1501989
CUSIP
23284F105
13F (30d)
139 filings
124 filers
Visit website
Investor relations